2022
Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial
Omer SB, O'Leary ST, Bednarczyk RA, Ellingson MK, Spina CI, Dudley MZ, Chamberlain AT, Limaye RJ, Brewer SE, Frew PM, Malik FA, Orenstein W, Halsey N, Ault K, Salmon DA. Multi-tiered intervention to increase maternal immunization coverage: A randomized, controlled trial. Vaccine 2022, 40: 4955-4963. PMID: 35817646, DOI: 10.1016/j.vaccine.2022.06.055.Peer-Reviewed Original ResearchConceptsPatient-level interventionsVaccine uptakeStudy armsInfluenza vaccineLow vaccine confidenceInfluenza vaccine uptakeAcellular pertussis vaccinePatient-level barriersProvider-level interventionsEvidence-based interventionsAcellular pertussisPertussis vaccinePrimary outcomeCare clinicsPregnant womenMulti-component intervention packageControl armImmunization uptakeObstetric practiceImmunization coverageSample sizeVaccine confidenceFinal sample sizeControl groupTargeted interventions
1999
The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein R, Flanigan T, Schuman P, Smith D, Vlahov D. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. The International Journal Of Tuberculosis And Lung Disease 1999, 3: 681-8. PMID: 10460100.Peer-Reviewed Original ResearchConceptsCell countSeronegative womenHigh-risk seronegative womenHuman immunodeficiency virus (HIV) infectionDelayed-type hypersensitivity testingDegree of immunodeficiencyHIV antibody testingImmunodeficiency virus infectionType hypersensitivity responseEffects of immunodeficiencyUrban medical centerDTH antigensDTH testingHIV seropositivesHIV-seronegativesPPD sizeSeropositive womenLymphocyte countHIV infectionAntibody testingHypersensitivity responseTuberculin antigenCutaneous responseHypersensitivity testingTetanus toxoid
1996
Tetanus and injections drug use: Rediscovery of a neglected problem?
Rezza G, Pizzuti R, De Campora E, De Masi S, Vlahov D. Tetanus and injections drug use: Rediscovery of a neglected problem? European Journal Of Epidemiology 1996, 12: 655-656. PMID: 8982630, DOI: 10.1007/bf00499469.Peer-Reviewed Original Research
1983
Adequacy of Antitetanus Prophylaxis in Six Hospital Emergency Rooms
Brand D, Acampora D, Gottlieb L, Glancy K, Frazier W. Adequacy of Antitetanus Prophylaxis in Six Hospital Emergency Rooms. New England Journal Of Medicine 1983, 309: 636-640. PMID: 6888430, DOI: 10.1056/nejm198309153091104.Peer-Reviewed Original ResearchConceptsHospital emergency roomAntitetanus prophylaxisEmergency roomOpen soft tissue injuriesHuman tetanus immunoglobulinMechanism of injurySoft tissue injuriesAdverse drug reactionsCost of carePast immunizationsTetanus immunoglobulinDrug reactionsTetanus toxoidDevitalized tissueImmunization protocolHigh riskDifferent hospitalsWound depthPatientsInjuryLower likelihoodProphylaxisTetanusPhysiciansBacterial contamination
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply